Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019Anil R. Maharaj, Michael Cohen‐Wolkowiez, P. Brian Smith et al.|Archives of Pediatrics and Adolescent Medicine|2020Cited by 47
Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected SubjectsAnil R. Maharaj, Andrea N. Edginton, Daniel González et al.|Clinical Pharmacokinetics|2017Cited by 34
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J. Balevic, Daniel González, Daniel Weiner et al.|Lupus Science & Medicine|2022Cited by 24
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical TrialsStephen J. Balevic, Michael Cohen‐Wolkowiez, Christoph P. Hornik et al.|The Journal of Rheumatology|2020Cited by 21
Dr. Balevic, <i>et al</i> replyStephen J. Balevic, Michael Cohen‐Wolkowiez, Geeta K. Swamy et al.|The Journal of Rheumatology|2020Cited by 1